Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$18.07 - $31.37 $290,927 - $505,057
16,100 New
16,100 $360,000
Q2 2021

Aug 16, 2021

SELL
$27.5 - $38.19 $173,525 - $240,978
-6,310 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$32.52 - $61.53 $146,177 - $276,577
-4,495 Reduced 41.6%
6,310 $218,000
Q4 2020

Feb 16, 2021

BUY
$35.51 - $54.03 $383,685 - $583,794
10,805 New
10,805 $449,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $588M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.